Pholcodine-induced Stevens-Johnson syndrome in a patient with COVID-19

Postgrad Med J. 2022 Jul;98(1161):499-500. doi: 10.1136/postgradmedj-2021-139892. Epub 2021 Apr 20.

Authors

Vedrana Bulat¹, Robert Likic², Nives Pondeljak¹, Marija Delas Azdajic¹

Affiliations

¹ Department of Dermatology and Venereology, University Hospital Centre Sestre Milosrdnice, Zagreb, Croatia.
² Department of Internal Medicine, Division of Clinical Pharmacology and Therapeutics, University Hospital Centre Zagreb, University of Zagreb School of Medicine, Zagreb, Croatia robert.likic@mef.hr.

PMID: 33879549
DOI: 10.1136/postgradmedj-2021-139892

No abstract available

Keywords: COVID-19; adverse events; clinical pharmacology; infectious diseases & infestations.

MeSH terms

COVID-19*
Codeine / analogs & derivatives
Humans
Morpholines
Stevens-Johnson Syndrome* / diagnosis
Stevens-Johnson Syndrome* / etiology

Substances

Morpholines
pholcodine
Codeine